J E Wraith

1.1k total citations
12 papers, 740 citations indexed

About

J E Wraith is a scholar working on Physiology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, J E Wraith has authored 12 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Rheumatology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in J E Wraith's work include Lysosomal Storage Disorders Research (10 papers), Glycogen Storage Diseases and Myoclonus (5 papers) and Metabolism and Genetic Disorders (2 papers). J E Wraith is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Glycogen Storage Diseases and Myoclonus (5 papers) and Metabolism and Genetic Disorders (2 papers). J E Wraith collaborates with scholars based in United Kingdom, United States and Australia. J E Wraith's co-authors include MA Cleary, R. A. Cowie, J. R. E. Fraser, MB Delatycki, J H Walter, Wayne Lam, Maureen Cleary, Chiedzo Mpofu, C. Whitehouse and Brian Fowler and has published in prestigious journals such as Archives of Disease in Childhood, Acta Paediatrica and Clinical Therapeutics.

In The Last Decade

J E Wraith

12 papers receiving 715 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J E Wraith United Kingdom 11 571 233 192 92 87 12 740
Ed Wraith United Kingdom 11 718 1.3× 242 1.0× 203 1.1× 149 1.6× 94 1.1× 24 910
Karen Tylee United Kingdom 16 580 1.0× 259 1.1× 158 0.8× 104 1.1× 107 1.2× 45 704
Suresh Vijayaraghavan United Kingdom 7 756 1.3× 373 1.6× 264 1.4× 98 1.1× 125 1.4× 11 862
Norberto Guelbert Argentina 16 514 0.9× 216 0.9× 232 1.2× 148 1.6× 105 1.2× 39 651
J. E. Wraith United Kingdom 20 692 1.2× 242 1.0× 434 2.3× 381 4.1× 76 0.9× 35 1.3k
Elke Miebach Germany 13 989 1.7× 521 2.2× 291 1.5× 133 1.4× 173 2.0× 15 1.1k
Rick Martin United States 8 989 1.7× 517 2.2× 376 2.0× 118 1.3× 136 1.6× 12 1.1k
K. Brühl Germany 11 250 0.4× 146 0.6× 79 0.4× 58 0.6× 66 0.8× 22 532
Ting‐Rong Hsu Taiwan 16 463 0.8× 217 0.9× 178 0.9× 201 2.2× 127 1.5× 53 780
Nesrin Karabul Germany 15 466 0.8× 130 0.6× 230 1.2× 101 1.1× 47 0.5× 24 580

Countries citing papers authored by J E Wraith

Since Specialization
Citations

This map shows the geographic impact of J E Wraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J E Wraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J E Wraith more than expected).

Fields of papers citing papers by J E Wraith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J E Wraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J E Wraith. The network helps show where J E Wraith may publish in the future.

Co-authorship network of co-authors of J E Wraith

This figure shows the co-authorship network connecting the top 25 collaborators of J E Wraith. A scholar is included among the top collaborators of J E Wraith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J E Wraith. J E Wraith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wraith, J E. (2008). Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II. Acta Paediatrica. 97(s457). 76–78. 29 indexed citations
2.
Clarke, L., J E Wraith, Michael Beck, et al.. (2007). A Phase III Extension Study of Aldurazyme®(Laronidase) in Mucopolysaccharidosis I. Clinical Therapeutics. 29. S111–S111. 2 indexed citations
3.
Wraith, J E. (2005). The first 5years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opinion on Pharmacotherapy. 6(3). 489–506. 115 indexed citations
4.
Fraser, J. R. E., J E Wraith, & MB Delatycki. (2002). Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians. Clinical Genetics. 62(5). 418–421. 44 indexed citations
5.
Wraith, J E. (2002). Lysosomal disorders. Seminars in Neonatology. 7(1). 75–83. 96 indexed citations
6.
Cleary, MA, et al.. (2002). Cardiovascular changes in children with mucopolysaccharide disorders. Acta Paediatrica. 91(7). 799–804. 55 indexed citations
7.
Lam, Wayne, Maureen Cleary, J E Wraith, & J H Walter. (1996). Histidinaemia: a benign metabolic disorder.. Archives of Disease in Childhood. 74(4). 343–346. 21 indexed citations
8.
Wraith, J E. (1995). The mucopolysaccharidoses: a clinical review and guide to management.. Archives of Disease in Childhood. 72(3). 263–267. 145 indexed citations
9.
Cleary, MA & J E Wraith. (1995). The presenting features of mucopolysaccharidosis type IH (Hurler syndrome). Acta Paediatrica. 84(3). 337–339. 69 indexed citations
10.
Cowie, R. A., et al.. (1995). Mucopolysaccharidosis type IVA (morquio syndrome): A clinical review. Journal of Inherited Metabolic Disease. 19(3). 357–365. 100 indexed citations
11.
Mpofu, Chiedzo, et al.. (1991). No sensory neuropathy during pyridoxine treatment in homocystinuria.. Archives of Disease in Childhood. 66(9). 1081–1082. 13 indexed citations
12.
Wraith, J E, et al.. (1990). Carpal tunnel syndrome in the mucopolysaccharidoses and related disorders.. Archives of Disease in Childhood. 65(9). 962–963. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026